AC
Athanor Capital Portfolio holdings
AUM
$24.6M
1-Year Return
2.48%
This Quarter Return
+13.66%
1 Year Return
+2.48%
3 Year Return
+113.29%
5 Year Return
+205.45%
10 Year Return
–
AUM
$2.81B
AUM Growth
+$634M
(+29%)
Cap. Flow
+$372M
Cap. Flow
% of AUM
13.25%
Top 10 Holdings %
Top 10 Hldgs %
28.25%
Holding
855
New
319
Increased
143
Reduced
170
Closed
180
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$104M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$49.7M |
| 3 |
CyberArk
CYBR
|
+$33.5M |
| 4 |
DuPont de Nemours
DD
|
+$31.7M |
| 5 |
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
|
+$29.5M |
Top Sells
| 1 |
Appian
APPN
|
+$42.7M |
| 2 |
Verizon
VZ
|
+$39.1M |
| 3 |
NBL
Noble Energy, Inc.
NBL
|
+$33.6M |
| 4 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$32.2M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$29.8M |
Sector Composition
| 1 | Technology | 17.68% |
| 2 | Consumer Discretionary | 16.76% |
| 3 | Communication Services | 11.01% |
| 4 | Financials | 9.69% |
| 5 | Industrials | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Lazard
LAZ
$5.3B
| $562K | 0.01% |
+13,296
| New | +$562K |
|
377
Polaris
PII
$3.35B
| $559K | 0.01% |
5,866
-4,440
| -43% | -$423K |
|
|
LHCG
378
DELISTED
LHC Group LLC
LHCG
| $558K | 0.01% |
+2,617
| New | +$558K |
|
379
TechTarget
TTGT
$421M
| $554K | 0.01% |
9,364
-15,472
| -62% | -$915K |
|
380
Coherus Oncology, Inc. Common Stock
CHRS
$159M
| $553K | 0.01% |
31,800
-3,210
| -9% | -$55.8K |
|
|
BHVN
381
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $550K | 0.01% |
+6,420
| New | +$550K |
|
382
Phathom Pharmaceuticals
PHAT
$882M
| $547K | 0.01% |
16,472
-68
| -0.4% | -$2.26K |
|
383
American Tower
AMT
$90.7B
| $545K | 0.01% |
+2,429
| New | +$545K |
|
|
VRTU
384
DELISTED
Virtusa Corporation
VRTU
| $543K | 0.01% |
+10,618
| New | +$543K |
|
385
Axalta
AXTA
$7.01B
| $540K | 0.01% |
+18,916
| New | +$540K |
|
386
Liberty Media Series A
FWONA
$23.1B
| $538K | 0.01% |
14,803
+2,667
| +22% | +$96.9K |
|
|
VYGG.U
387
DELISTED
Vy Global Growth Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant to acquire one Class A Ordinary Share
VYGG.U
| $538K | 0.01% |
+50,000
| New | +$538K |
|
388
NOV
NOV
$4.92B
| $536K | 0.01% |
39,048
-52,885
| -58% | -$726K |
|
389
Moelis & Co
MC
$5.37B
| $535K | 0.01% |
11,443
-4,673
| -29% | -$218K |
|
390
Cytokinetics
CYTK
$6.23B
| $533K | 0.01% |
+25,649
| New | +$533K |
|
391
Keros Therapeutics
KROS
$628M
| $532K | 0.01% |
+7,547
| New | +$532K |
|
392
Kura Oncology
KURA
$707M
| $532K | 0.01% |
16,289
-4,129
| -20% | -$135K |
|
393
Labcorp
LH
$23B
| $528K | 0.01% |
+3,021
| New | +$528K |
|
394
Invesco
IVZ
$9.81B
| $526K | 0.01% |
+30,155
| New | +$526K |
|
|
ADAP
395
Adaptimmune Therapeutics
ADAP
$11.3M
| $524K | 0.01% |
97,240
+34,492
| +55% | +$186K |
|
396
Rhythm Pharmaceuticals
RYTM
$6.63B
| $524K | 0.01% |
17,631
+5,211
| +42% | +$155K |
|
397
Revvity
RVTY
$10B
| $519K | 0.01% |
+3,615
| New | +$519K |
|
398
Cboe Global Markets
CBOE
$24.5B
| $517K | 0.01% |
+5,554
| New | +$517K |
|
|
BBBY
399
Bed Bath & Beyond, Inc.
BBBY
$595M
| $514K | 0.01% |
10,718
-2,386
| -18% | -$114K |
|
400
Power Integrations
POWI
$2.52B
| $512K | 0.01% |
6,249
-10,701
| -63% | -$877K |
|